Quick Search

  Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home

  Pharmacist Nutriceuticals®
  USA Best®
  Health Concerns
  Sexual Health
  Specialty Supplements
  Vitamins & Minerals
  Weight Loss
  Sports & Athletic Nutrition
  Extreme Hardcore Body Building
  Body Shaping
  Amino Acids
  Food Bars
  Branded Ingredients
  Press Releases
  Company Policy
ANTI-OXIDANT [click to enlarge]
USALAO60C - 3#

MSRP: $26.99
Internet Direct: $21.99


60 Caps - Contains Vitamins A, C, B1, B2, B3, B5, B6, Selenium, plus much more!
*Finally, a Pharmacist researched True ANTI-OXIDANT is here!
60 Capsules
*Finally, a Pharmacist researched True ANTI-OXIDANT is here!

Pharmacist References:

Vitamin C References:
1. Balz F. Antioxiant vitamins and heart disease. Presented at the 60th Annual Biology Colloquium, Oregon State University, Corvallis, Oregon, February 25, 1999.
2. Hemilš H. Does vitamin C alleviate the symptoms of the common cold? A review of current evidence Scand J Infect Dis 1994;26:1-6
3. Taddei S, Virdis A, Ghaidoni L, et al. Vitamin C improves endotheoium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222-29
4. Chambers JC, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy. Circulation 1999;99:1156-60.
5. Taylor A. Cataract: relationship between nutrition and sxidation. J Am Coll Nutr 1993;12:138-46 [review].
6. Taylor A, Jacques PF, Nadler D, et al. Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humor, and plasma. Curr Eye Res 1991;10:751-59.
7. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991;53:352S-55S
8. Jacques PF, Chylack LT, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988;106:337-40.
9. Robertson JM, Donner AP, Trevithick JR. vitamin E intake and risk of cataracts in humans Ann Nrl Acad Sci 1989;570:372-82.
10. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health 1994;84:788-792.
11. Vincent TE, mendiratta S, may JM. Inhibition of aldose reductase in human erythrocytes by vitamin C. diabetes Res Clin Pract1 999;43:1-8.
12. Simon JA. Ascorbic acid and cholesterol gallstones. Med Hypotheses 1993;40:81-84.
13. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996;93:3704-709
14. Sandstead HH. Copper bioavailability and requirements. Am J clin Nutr 1982;35:809-14 [review].
15. Finley EB, Cerklewski FL. Influence of ascorbic acid supplementation on copper status in yound adult men. Am J Clin Nutr 1983;37:553-56.
16. Piesse JW. Nutritional factors in calcium containing kidney stones wiht particular emphasis on vitamin C. Int Clin Nutr Rev 1985;5(3):110-129 [review]
17. Ringsdorf WM, Cheraskin WM. Medical complications from ascorbic acid: review and interpretation (part one). J Holistic Med 1984;6(1):49-63.
18. Hoffer A. Ascorbic acid and kidney stones. Can Med Assoc J 1985;32:320 [letter]
19. Wandzilak TR, D'Andre SD, Davis PA, Williams HE. Effect of high dose vitamin C on urinary oxal levels. J Urol 1994;151:834-37.
20. Levine M. Vitamin C and optimal health. Presented at the February 25, 1999 60th Annual Biology Colloquium, Oregon State University, Corvallis, Oregon.
21. Levine M, Conry-Cantilena C, wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers:evidnece for a recommended dietary allowance. proc Natl Acad Sci USA 1996;93:3704-709.
22. Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998;28:695-700.

Bioflavonoids References:
1. Peterson J, Dwyer J. Taxonomic classification helps identify flavonoid-containing foods on a semiquantitative food frequency questionnaire. J Am Dietet Assoc
2. So FV Guthrie N, Chambers AF, et al. Inhibition of human breast cancer cell proliferation and dela of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996;26:167-81.
3. Pamukcu AM, Yalciner S, Hatcher JF, Bryan GT. Quercetin, a rat intestinal and bladder carcinoger present in braken fern (Pteridium aquilinum). Cancer Res
4. Hirono I, Ueno I, Hosaka S, Takanashi H, et al. Carcinogenicity examination of quercetin and rutin ACI rats. Cancer Lett 1981;13:15-21.
5. Saito D, Shirai A, Matsushima T, et al. Test of carcinogenticity of quercetin, a widely distributed mutage in food. Teratog Garcinog Mutagen 1980;1:213-21.
6. Aeschbacher H-U, Meier H, Ruch E. Nonmutagenicity in vivo of the food flavonol quercetin. Nutr Cancer 1982;2:90.
7. Nishino H, Nishino A, Iwashima A, et al. Quercetin inhibits the action of 12-O-tetradecanoylphorbol-13acetate, a tumor promoter. Oncology 1984;41:120-23.
8. Kuo SM. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996;110:41-48.
9. Knekt P, Javinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997;146:223-30.
10. Hertog M, Feskens EFM, Hollman PCH, et al. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 1994;22:175-84.
11. Stavric B. Quercetin in our diet: from potent mutagen to probable anticarcinogen. Clin Biochem 1994;27:245-48.
12. Vinson JA, Bose P. Comparative bioavailability to humans of ascorbic acid alone or in a citrus extract. Am J Clin Nutr 1988;48:601-4.
13. Vinson JA, Bose P. Comparative bioavailability of synthetic and natural vitamin C in Guinea pigs. Nutr Rep Intl 1983;27 (4):875.

Cysteine References:
1. Salim AS. Sulfhydryl-containing agents in the treatment of gastric bleeding induced by nonsteroidal anti-inflammatory drugs. Can j Surgery 1993;36:53-58.
2. Droge W, Eck HP, Gander H, Mihm S. Modulation of lymphocyte functions and immune response by cysteine and cysteine derivatives. Am J Med
1991;91(suppl 3C): 140S-44S.
3. Eck HP, Gander H, Hartmann M, et al. Biol Chem Hoppe Seyler 1989;370:101-8.
4. Droge W, Eck HP, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acteylcysteine. Immunol Today 1992;13:211-14.
5. Droge W. Cysteine and glutathione deficiency in AIDS patients: A rationale for the treatment with N-acetyl-cysteine. Pharmacol 1993;46:61-65.
6. Kleinveld HA, Demacker PNM, Stalenhoef AFH. Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy sugjects. Eur J Clin Pharmacol 1992;639-42.
7. Olney JW, Ho O-L. Brain damage in infant mice following oral intake of glutamante, aspartate or cysteine. Nature 1970;227:609-10 [letter].

Choline References:
1. Benjamin J, Levine J. Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995;152:1084-86.

Vitamin E References:
1. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450-56.
2. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1444-49.
3. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-86.
4. Christen S, Woodall AA, Shigenage MK, Southwell-Keely, Duncan MW, Ames BN. Gamma-tocopherol traps mutagenic electrophiles such as NO+ and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci 1997;94:3217-22.
5. Rimm E. Micronutrients, Coronary Heart disease and cancer: Should we all be on supplements? Presented at the 60th Annual Biology Colloquium, Oregon State University, February 25, 1999.

Methionine References:
1. Muller f et al. Elevated plasma concentration of reduced homocysteine in patients with Human Immunodeficiency Virus infection. Am J Clin Nutr 1996;242-46.
2. Revillard JP. Lipid peroxidation in Human immunodefeciency Virus infection. J Acquired Immunode Synd 1992;5:637-38.
3. Singer P et al. Nutritional aspects of the Acquired Immunodefeciency Syndrome. Am J Gastroenter 1992;87:265-73.
4. Tan SV, Guiloff RJ. Hypothesis on the pathongenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiat 1998 65:23-25.
5. Keating JN et al. Evidences of brain methyltransferase inhibition and early brain involvement in HIV-positive patients. Lancet 1991;337:935-39.
6. Dorfman D, DiRocco A, Simpson D, et al. Oral methionine may improve neuropsychological function in patients with AIDS myelopathy: results of an open-label trial. AIDS 1997;11:1066-67.
7. Smythies JR, Halsey JH. Treatment of Parkinson's disease with l-methionine. Shouth Med J 1974;77:1577.
8. Uden S, Bilton D, Nathan L, et al. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther 1990;4:357-71.
9. Shaw GM, Velle EM, Schaffer DM. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-associated pregnancies? Teratology
10. Toborek M, Hennig B. Is methionine an atherogenci amino acid? J Optimalt Nutr 1994;3(2):80-8.
11. Leach FN, Braganza JM. Methionine is important in treatment of chronic pancreatitis. Br Med J 1998;316:474 [letter].

Vitamin A References:
1. Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369-73.
2. Mastroiacovo P, Mazzone T, Addis A, et al. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology 1999;59:7-11.
3. Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr 1989;49:358-71.
4. Mejiaa LA, Chew F. Hematological effect of supplementing anemic children with vitamin A alone and a combination with iron. Am J Clin Nutr 1988;48:595-600.

Vitamin B1 References:
1. Cheraskin E, Ringsdorf WM, Medford FH, Hicks BS. The "ideal" daily vitamin B1 intake Oral Med 1978;33:77-79.

Vitamin B2 References:

1. Bhat Nutritional status of thiamine, riboflavin and pyridoxine in catarct patients. Nutr Rep Inter 1987;36:685-92.

Vitamin B5 References:
1. Fidanza A. Therapeutic action of pantothenic acid. Int J Vit Nutr Res 1983;supple 24:53-67 [review].

Vitamin B6 References:
1. Keniston RC, Nathan PA, Leklem JE, Lockwood Rs. Vitamin B6, vitamin C, and carpal tunnel syndrome. J Occup Environ Med 1997;39:949-59.
2. Franzblau A, Rock CL, Werner RA, et al. The relationship of vitamin B6 status to median nerve function and carpal tunnel syndrome among active industrial workers. J Occup Environ Med 1996;38:485-91.
3. Smith GP, Rudge PJ, Peters TJ. Biochemical studies of pyridoxal and pyridoxal phosphate status and therapeutic trial of pyridoxine in patients with carpal tunnel syndrome. Ann Neurol 1984;15:104-107.
4. Gaby AR. Literature review & commentary. Townsend Letter for Doctors June 1990;338-39.
5. Parry G, Bredesen DE. Sensory neuropath with low-dose pyridoxine. Neurology 1985;35:1466-68.
6. Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse. N England Med 1983;309(8):445-48.

Glutamine References:
1. Robinson MK et al. Glutathione deficiency and HIV infection. Lancet 1992;339:1603-4.
2. Grffiths RD. Outcome of critically ill patients after supplementation with glutamine. Nutrition 1997;13:752-54.

Selenium References:
1. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-63.
2. Yoshizawa K, Wilett WC, Morris SJ, et al. Study of prediagnostic selenium levels in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24.
3. Yu S-Y, Li W-G, Zhu Y-J, et a. Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol Trace Element Res 1989;20:15-20.
4. Peretz A, Neve J, Desmedt J, et al. Lymphocyte response is enhanced by supplementation of elde subjects with selenium-enriched yeast. Am J Clin Nutri 1991;53:1323-28.
5. Scott R, Mocpherson A, Yates RWS, et al. The effect of oral selenium supplementation on human sperm motitlity. Br J Urol 1998;82:76-80.
6. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Iteract 1994;91:181-869.
7. Moore JA, Noiva R, Wells IC. Selenium concentrations in plasma of patients with arteriographically defined coronary atherosclerosis. Clin Chem 1984;30:1171-73.
8. Contempre B, Dumont JE, Ngo B, et al. Effects of selenium supplementation in hypothyroid subject of an iodine and selenium deficient area: The possible danger of indiscriminate supplementation of iodine deficient subjects with selenium. J Clin Endocrinol Metabol 1991;73:213-15.

  • Back To List
  • Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home  l  Return to Top of Page

        Nasvhille Chamber of Commerce Dickson County Chamber of Commerce U.S. Commercial Service

    *These statements have not been evaluated by the F.D.A. *USA Laboratories makes no representation or warranties concerning the use of our products for the diagnosis, cure, mitigation, treatment or prevention of any disease. *Seek advice from a health care provider before using this or any supplement product.

    Powered By LionZone Copyright © USA LABORATORIES, INC. All rights reserved.